The trajectory of Viagra presents a challenging picture for investors. While the initial release generated massive returns, the expiration of its patent opened the floodgates to off-brand competitors, dramatically https://thesocialroi.com/story11617131/the-copyright-and-big-pharma-a-precarious-bet